NCT07610668

Brief Summary

This study selected patients who underwent cesarean section and were scheduled to undergo Saline Infusion Sonohysterography (SIS) for evaluating the structure of the incision. Clinical characteristics and clinical symptoms were collected. Combined with hysteroscopy, MRI, conventional ultrasound and SIS examination results, the study analyzed the detection rate of cesarean section diverticula by SIS, the changes in diverticulum size and the diagnostic efficacy of residual muscle layer thickness at the incision site. The surgical methods and clinical symptom improvement of patients with CSD after surgery were followed up for half a year to one year. The study aimed to clarify the guiding value of SIS in clinical decision-making and patient prognosis for patients, and to analyze the etiological relationship between the true incidence of CSD and clinical complications. Thus, it provided evidence-based basis for clinical events of cesarean section surgery → CSD → CSD complications → surgical treatment of CSD → patient prognosis, promoting the progress of precise diagnosis and treatment of female reproductive health.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jan 2023Jul 2026

Study Start

First participant enrolled

January 1, 2023

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

May 18, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 28, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

May 28, 2026

Status Verified

May 1, 2026

Enrollment Period

3.5 years

First QC Date

May 18, 2026

Last Update Submit

May 26, 2026

Conditions

Keywords

Saline Infusion SonohysterographyTransvaginal ultrasonographyCesarean scar diverticulumResidual myometrial thickness

Outcome Measures

Primary Outcomes (3)

  • The detection rate of cesarean scar diverticulum

    The detection rate of cesarean scar diverticulum refers to the proportion of patients in whom the diverticulum is identified through various diagnostic modalities among all patients examined.

    Day 1

  • Clinical Pregnancy Rate

    The clinical pregnancy rate is defined as the proportion of patients with the presence of at least one intrauterine gestational sac with a visible fetal heartbeat, confirmed by transvaginal ultrasound.

    Up to 90 days of gestation

  • Residual myometrial thickness

    The Residual myometrial thickness refers to the thickness of the myometrial layer at the uterine lower segment at the site of prior cesarean delivery.

    Day 1

Study Arms (1)

This group of patients received appropriate treatment based on the presence or absence of diverticul

The treatment plan was determined by the attending physician according to clinical guidelines and was strictly independent of this observational study protocol.

Procedure: diverticulum reconstruction surgery

Interventions

This group of patients received conventional infertility treatment only, without undergoing diverticulum reconstruction surgery, in accordance with standard clinical practice.

This group of patients received appropriate treatment based on the presence or absence of diverticul

Eligibility Criteria

Age20 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The research population comprised adult women with a prior cesarean delivery who presented to Tangdu Hospital with symptoms including abnormal uterine bleeding, dysmenorrhea, prolonged menstrual spotting, or secondary infertility.

You may qualify if:

  • More than 6 months after cesarean delivery;
  • Presenting with clinical symptoms-including abnormal uterine bleeding, dysmenorrhea, prolonged menstrual spotting, or secondary infertility;
  • Requiring saline infusion sonohysterography (SIS) to evaluate the cesarean scar.

You may not qualify if:

  • Multiple cesarean deliveries;
  • Patients contraindicated for saline infusion sonohysterography (SIS), including pregnancy or suspected pregnancy, failure to meet vaginal hygiene criteria, inability to cooperate during the procedure, or suboptimal image quality;
  • Cases with incomplete clinical data or lost to follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tang-Du Hospital

Xi'an, Shaanxi, 710038, China

RECRUITING

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Li Zhang, MD

    The Second Affiliated Hospital of Air Force Military Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Chief Physician

Study Record Dates

First Submitted

May 18, 2026

First Posted

May 28, 2026

Study Start

January 1, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

May 28, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) underlying the results reported in the published article will be shared. Data will be available to researchers who provide a methodologically sound proposal, purely for the purpose of achieving the aims in the approved proposal.

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
Data will be available beginning 6 months and ending 36 months following article publication.
Access Criteria
To gain access, data requestors will need to contact the corresponding author and sign a formal data access agreement.

Locations